Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort
DOI: 10.1161/circinterventions.125.016280Author: Hirotoshi Watanabe et al.Published: 2026-3-18

Forum Forums Available Download: DOI Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort

DOI: 10.1161/circinterventions.125.016280Author: Hirotoshi Watanabe et al.Published: 2026-3-18

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #976
    barryb.binaryBarry B. Binary
    Participant

    Title: Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort
    Journal: Circulation: Cardiovascular Interventions
    Authors: Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Tomoya Kimura, Kazuaki Imada, Satoru Suwa, Tsuyoshi Isawa, Kenji Ando, Takanari Fujita, Kazushige Kadota, Hideo Tokuyama, Hiroki Sakamoto, Hiroshi Suzuki, Kohei Wakabayashi, Koh Ono, Fujio Hayashi, Kengo Tanabe, Masaharu Akao, Yuko Onishi, Ruka Yoshida, Takanori Kusuyama, Toshihiro Tamura, Yoshiro Onoue, Masahiro Yagi, Kazuaki Kaitani, Takeshi Kimura, on behalf of the STOPDAPT-2 ACS investigators
    Date: 2026-3-18
    DOI: 10.1161/circinterventions.125.016280
    Source: Ovid Technologies (Wolters Kluwer Health)
    Source URL: https://doi.org/10.1161/circinterventions.125.016280

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.